Scholarlink

Background <p><i>Candida albicans</i> is a significant opportunistic pathogen in pediatric respiratory infections, yet systematic analyses of its role in hospitalized children remain scarce. This study evaluates the prevalence, clinical profiles, and outcomes of <i>C. albicans</i>-associated respiratory infections in this population.</p> Methods <p>From April 2021 to December 2024, 10,310 pediatric inpatients with respiratory infections at Guangxi Zhuang Autonomous Region Maternal and Child Health Hospital underwent pathogen screening via targeted next-generation sequencing (tNGS).</p> Results <p><i>C. albicans</i> was detected in 5.0% (511/10,310), with detection rates varying by specimen: highest in sputum (10.3%), followed by bronchoalveolar lavage fluid (8.8%), and minimal in throat swabs (0.3%). Co-infections occurred in 99.0% (506/511), predominantly involving <i>Mycoplasma pneumoniae</i> (189), <i>Haemophilus influenzae</i> (174), and Rhinovirus (169). ICU patients (6.3%) demonstrated elevated inflammatory markers (PCT: 0.31 vs. 0.08 ng/mL; D-dimer: 795 vs. 360 ng/mL FEU; <i>P</i> &lt; 0.001), prolonged hospitalization (median 17 vs. 7 days, <i>P</i> &lt; 0.001), and distinct pathogens (<i>Acinetobacter baumannii</i> vs. <i>M. pneumoniae</i> in non-ICU). 51.7% and 35.4% of the children experienced respiratory and other systemic complications, respectively. Among the 511 children diagnosed with <i>C. albicans</i> infection, 32 (6.3%) required ICU admission for monitoring. The median duration of hospitalization for these 511 children was 7 days. Of these, 482 (94.3%) recovered and were discharged following treatment, while 26 (5.0%) had family members who requested voluntary discharge due to unsatisfactory outcomes or other reasons. Unfortunately, 3 children (0.6%) died despite receiving intensive medical treatment.</p> Conclusion <p>This large-scale tNGS-based study addresses critical knowledge gaps, revealing ICU-specific pathogen profiles (<i>A. baumannii</i>), high co-infection burdens (99.0%), and complications linked to prematurity/immunodeficiency. The predominance of lower respiratory tract involvement (sputum/BALF positivity) underscores the need for specimen-selective diagnostics. Findings advocate for optimized tNGS protocols, ICU-tailored antimicrobial strategies, and early interventions in high-risk subgroups to reduce morbidity (e.g., sepsis risk) and socioeconomic burdens.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

High co-infection burden and ICU-specific pathogen profiles in pediatric Candida albicans respiratory infections: a large-scale tNGS analysis

  • 期刊论文

  • 发表日期：

    2025年7月18日

查看全文
  • Ya Huang,
  • Huideng Zhou,
  • Jiangyang Zhao,
  • Lishai Mo,
  • Junming Lu,
  • Guangbing Liu,
  • Shuo Zhang,
  • Yanhua Feng,
  • Wenting Tang,
  • Qiang Huang,
  • Yan Chen,
  • Cuihong Lu,
  • Xuehua Hu,
  • Ruting Chen,
  • Jiaqi Wen,
  • Yanqing Tang,
  • Shang Yi,
  • Hao Wei,
  • Jielin Chen,
  • Huiping Huang,
  • Jie Tan,
  • Chunyun Fu

摘要

Background

Candida albicans is a significant opportunistic pathogen in pediatric respiratory infections, yet systematic analyses of its role in hospitalized children remain scarce. This study evaluates the prevalence, clinical profiles, and outcomes of C. albicans-associated respiratory infections in this population.

Methods

From April 2021 to December 2024, 10,310 pediatric inpatients with respiratory infections at Guangxi Zhuang Autonomous Region Maternal and Child Health Hospital underwent pathogen screening via targeted next-generation sequencing (tNGS).

Results

C. albicans was detected in 5.0% (511/10,310), with detection rates varying by specimen: highest in sputum (10.3%), followed by bronchoalveolar lavage fluid (8.8%), and minimal in throat swabs (0.3%). Co-infections occurred in 99.0% (506/511), predominantly involving Mycoplasma pneumoniae (189), Haemophilus influenzae (174), and Rhinovirus (169). ICU patients (6.3%) demonstrated elevated inflammatory markers (PCT: 0.31 vs. 0.08 ng/mL; D-dimer: 795 vs. 360 ng/mL FEU; P < 0.001), prolonged hospitalization (median 17 vs. 7 days, P < 0.001), and distinct pathogens (Acinetobacter baumannii vs. M. pneumoniae in non-ICU). 51.7% and 35.4% of the children experienced respiratory and other systemic complications, respectively. Among the 511 children diagnosed with C. albicans infection, 32 (6.3%) required ICU admission for monitoring. The median duration of hospitalization for these 511 children was 7 days. Of these, 482 (94.3%) recovered and were discharged following treatment, while 26 (5.0%) had family members who requested voluntary discharge due to unsatisfactory outcomes or other reasons. Unfortunately, 3 children (0.6%) died despite receiving intensive medical treatment.

Conclusion

This large-scale tNGS-based study addresses critical knowledge gaps, revealing ICU-specific pathogen profiles (A. baumannii), high co-infection burdens (99.0%), and complications linked to prematurity/immunodeficiency. The predominance of lower respiratory tract involvement (sputum/BALF positivity) underscores the need for specimen-selective diagnostics. Findings advocate for optimized tNGS protocols, ICU-tailored antimicrobial strategies, and early interventions in high-risk subgroups to reduce morbidity (e.g., sepsis risk) and socioeconomic burdens.